Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.
Publication
, Conference
Ghiaseddin, A; Reardon, D; Massey, W; Mannerino, A; Lipp, E; Herndon, J; McSherry, F; Desjardins, A; Randazzo, D; Vlahovic, G; Friedman, H; Peters, K
Published in: Journal of Clinical Oncology
May 20, 2015
2034
Duke Scholars
Published In
Journal of Clinical Oncology
Publication Date
May 20, 2015
Volume
33
Issue
15s, Part I of II
Start / End Page
104s / 104s
Location
McCormick Place, Chicago, IL
Publisher
American Society of Clinical Oncology
Conference Name
2015 ASCO Annual Meeting
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ghiaseddin, A., Reardon, D., Massey, W., Mannerino, A., Lipp, E., Herndon, J., … Peters, K. (2015). Phase II study of bevacizumab and vorinostat for recurrent glioblastoma. In Journal of Clinical Oncology (Vol. 33, pp. 104s-104s). McCormick Place, Chicago, IL: American Society of Clinical Oncology.
Ghiaseddin, Ashley, David Reardon, Woody Massey, Alexandra Mannerino, Eric Lipp, James Herndon, Frances McSherry, et al. “Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.” In Journal of Clinical Oncology, 33:104s-104s. American Society of Clinical Oncology, 2015.
Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp E, Herndon J, et al. Phase II study of bevacizumab and vorinostat for recurrent glioblastoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology; 2015. p. 104s-104s.
Ghiaseddin, Ashley, et al. “Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.” Journal of Clinical Oncology, vol. 33, no. 15s, Part I of II, American Society of Clinical Oncology, 2015, pp. 104s-104s.
Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp E, Herndon J, McSherry F, Desjardins A, Randazzo D, Vlahovic G, Friedman H, Peters K. Phase II study of bevacizumab and vorinostat for recurrent glioblastoma. Journal of Clinical Oncology. American Society of Clinical Oncology; 2015. p. 104s-104s.
Published In
Journal of Clinical Oncology
Publication Date
May 20, 2015
Volume
33
Issue
15s, Part I of II
Start / End Page
104s / 104s
Location
McCormick Place, Chicago, IL
Publisher
American Society of Clinical Oncology
Conference Name
2015 ASCO Annual Meeting
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences